| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.00B | — |
| Operating expense | — | — |
| Net income | -1.48M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RV6.F returned +85.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +48.8% |
| 1 year | +85.7% |
| 5 years | -31.6% |
| 10 years | +241.2% |
| All-time high | €374.00 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in RV6.F would be worth today ›No. Charles River Laboratories International, Inc. has not paid a dividend in the past 12 months.
Charles River Laboratories International, Inc. is part of the Healthcare sector.
Charles River Laboratories International, Inc. has a market cap of 12.21B EUR, based on the latest quote.
Charles River Laboratories International, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
